590782388	590782388	CD	B-NP	O
|	|	NN	I-NP	O
DNH	DNH	NN	I-NP	O
|	|	NN	I-NP	O
87702030	87702030	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6512995	6512995	CD	B-NP	O
|	|	CC	I-NP	O
7/6/2006	7/6/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/2/2006	6/2/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/3/2006	3/3/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
BALIS	BALIS	NN	B-NP	O
,	,	,	O	O
NORBERTO	NORBERTO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
FHCC	FHCC	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NN	B-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

ASSOCIATED	ASSOCIATED	VBN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
embolic	embolic	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
on	on	IN	B-PP	O
5/15	5/15	CD	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
on	on	IN	B-PP	O
3/1/06	3/1/06	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
temporal	temporal	JJ	B-NP	O
lobe	lobe	NN	I-NP	O
epilepsy	epilepsy	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ADD	ADD	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Stage	Stage	NN	B-NP	O
III	III	CD	I-NP	O
non-small-cell	non-small-cell	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
chemo	chemo	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Graves	Graves	NN	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
subclavian	subclavian	JJ	B-NP	O
steal	steal	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
right-handed	right-handed	JJ	I-NP	O
lady	lady	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
non-small-cell	non-small-cell	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
stroke	stroke	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
CEA	CEA	NN	I-NP	O
on	on	IN	B-PP	O
3/1/06	3/1/06	CD	B-NP	O
for	for	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
temporal	temporal	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
epilepsy	epilepsy	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medicine	medicine	NN	I-NP	O
service	service	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
for	for	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cough	cough	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
2/24/06	2/24/06	CD	B-NP	O
to	to	TO	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
for	for	IN	B-PP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
UTI	UTI	NN	I-NP	O
but	but	CC	O	O
grew	grow	VBD	B-VP	O
with	with	IN	B-PP	O
yeast	yeast	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
by	by	IN	B-PP	O
neurology	neurology	NN	B-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
somnolence	somnolence	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
that	that	WDT	B-NP	O
shows	show	VBZ	B-VP	O
encephalomalacia	encephalomalacia	NN	B-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
distribution	distribution	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
old	old	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
hemorrhages	hemorrhage	NNS	I-NP	O
,	,	,	O	O
midline	midline	NN	B-NP	O
shifts	shift	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
mass	mass	NN	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
definite	definite	JJ	I-NP	O
metastatic	metastatic	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
oncologist	oncologist	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
excellent	excellent	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
EEG	EEG	NN	I-NP	O
.	.	.	O	O

MRI/MRA	MRI/MRA	NN	B-NP	O
always	always	RB	B-ADVP	O
shows	show	VBZ	B-VP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
MCA	MCA	NNP	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
B12	B12	NN	I-NP	B-protein
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
RPR	RPR	NN	B-NP	B-protein
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
agreed	agree	VBD	B-VP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
somnolence	somnolence	NN	B-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
leptomeningeal	leptomeningeal	JJ	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
neurological	neurological	JJ	B-NP	O
finding	finding	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	O
nursing	nursing	NN	I-NP	O
and	and	CC	O	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
house	house	NN	B-NP	O
staff	staff	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
waxing	wax	VBG	I-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
appearing	appear	VBG	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
appropriate	appropriate	JJ	I-NP	O
and	and	CC	I-NP	O
other	other	JJ	I-NP	O
times	time	NNS	I-NP	O
somewhat	somewhat	RB	B-VP	O
hallucinating	hallucinate	VBG	I-VP	O
and	and	CC	O	O
agitated	agitate	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
urination	urination	NN	B-NP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
eating	eat	VBG	I-VP	O
adequately	adequately	RB	B-ADVP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
sticking	stick	VBG	B-VP	O
out	out	RP	B-PRT	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
mouth	mouth	NN	I-NP	O
and	and	CC	O	O
not	not	RB	O	O
quite	quite	RB	B-ADJP	O
responsive	responsive	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
7/26/06	7/26/06	CD	B-NP	O
that	that	WDT	B-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
hilar	hilar	JJ	I-NP	O
mass	mass	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
moxifloxacin	moxifloxacin	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
7/26/06	7/26/06	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
here	here	RB	B-ADVP	O
at	at	IN	B-PP	O
Kendertawn	Kendertawn	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
son	son	NN	I-NP	O
's	's	POS	B-NP	O
request	request	NN	I-NP	O
for	for	IN	B-PP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
presumed	presume	VBN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
98.8	98.8	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
122	122	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/68	160/68	CD	I-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
got	get	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
postobstructive	postobstructive	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
dirty	dirty	JJ	I-ADJP	O
with	with	IN	B-PP	O
oxalate	oxalate	NN	B-NP	O
crystal	crystal	NN	I-NP	O
,	,	,	O	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
100	100	CD	B-NP	O
+	+	SYM	I-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
change	change	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
shows	show	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
right	right	JJ	I-NP	O
MCA	MCA	NNP	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Right	Right	NNP	B-NP	O
MCA	MCA	NNP	I-NP	O
embolic	embolic	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
5/15	5/15	CD	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
ICA	ICA	NN	I-NP	O
on	on	IN	B-PP	O
3/1/06	3/1/06	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
temporal	temporal	JJ	B-NP	O
lobe	lobe	NN	I-NP	O
epilepsy	epilepsy	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Amado	Amado	NNP	B-NP	O
Routzen	Routzen	NNP	I-NP	O
at	at	IN	B-PP	O
CIH	CIH	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ADD	ADD	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Stage	Stage	NN	B-NP	O
III	III	CD	I-NP	O
non-small-cell	non-small-cell	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
chemo	chemo	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Graves	Graves	NN	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
subclavian	subclavian	JJ	B-NP	O
steal	steal	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
radioactive	radioactive	JJ	B-NP	O
iodine	iodine	NN	I-NP	O
for	for	IN	B-PP	O
Graves	Graves	NN	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cymbalta	Cymbalta	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

Lamictal	Lamictal	JJ	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Zydis	Zydis	NNP	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subq	subq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
125	125	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Ritalin	Ritalin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Compazine	Compazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Lidoderm	Lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Dilaudid	Dilaudid	VBD	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

APAP	APAP	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
b.i.d.	b.i.d.	JJ	B-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
To	To	TO	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
hive	hive	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
valproic	valproic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	I-NP	O
sulfa	sulfa	NN	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

Demerol	Demerol	NN	B-NP	O
causes	cause	VBZ	B-VP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
recently	recently	RB	B-ADVP	O
.	.	.	O	O

100-pack-year	100-pack-year	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
but	but	CC	O	O
quit	quit	NN	B-NP	O
,	,	,	O	O
occasionally	occasionally	RB	B-ADVP	O
still	still	RB	B-ADVP	O
asks	ask	VBZ	B-VP	O
for	for	IN	B-PP	O
cigarettes	cigarette	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
feels	feel	NNS	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
better	well	RBR	B-ADVP	O
on	on	IN	B-PP	O
nicotine	nicotine	NN	B-NP	O
patch	patch	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	O
at	at	IN	B-PP	O
73	73	CD	B-NP	O
,	,	,	O	O
mother	mother	NN	B-NP	O
died	die	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
80s	80	NNS	I-NP	O
of	of	IN	B-PP	O
emphysema	emphysema	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.8	98.8	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
122	122	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
116/68	116/68	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
chronically	chronically	RB	I-NP	O
ill-appearing	ill-appearing	JJ	I-NP	O
,	,	,	I-NP	O
minimally	minimally	RB	I-NP	O
verbal	verbal	JJ	I-NP	O
,	,	,	O	O
responding	respond	VBG	B-VP	O
to	to	TO	B-PP	O
commands	command	NNS	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
dry	dry	JJ	B-NP	O
mucus	mucus	NN	I-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
oral	oral	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
healing	heal	VBG	B-VP	O
incisions	incision	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Rhonchorous	Rhonchorous	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
right	right	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	NNP	B-NP	O
:	:	:	O	O
Tachy	Tachy	NNP	B-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
rub	rub	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallop	gallop	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
quadrant	quadrant	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
contraction	contraction	NN	B-NP	O
from	from	IN	B-PP	O
upper	upper	JJ	B-NP	O
extremity	extremity	NN	I-NP	O
from	from	IN	B-PP	O
stroke	stroke	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
worse	worse	JJR	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
hand	hand	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
brace	brace	NN	I-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
,	,	,	O	O
petechiae	petechiae	FW	B-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Oriented	Oriented	NNP	B-NP	O
x2	x2	CD	I-NP	O
,	,	,	O	O
waxing	wax	VBG	B-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
Left-sided	Left-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
0/5	0/5	CD	B-NP	O
strength	strength	NN	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
1/5	1/5	CD	B-NP	O
strength	strength	NN	I-NP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
reflexes	reflex	NNS	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
are	be	VBP	B-VP	O
basically	basically	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

Lytes	Lyte	NNS	B-NP	O
;	;	:	O	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
14.2	14.2	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
37.6	37.6	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
polyps	polyp	NNS	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
remarkable	remarkable	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
alkaline	alkaline	JJ	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
126	126	CD	B-NP	O
.	.	.	O	O

Albumin	Albumin	NNP	B-NP	O
is	be	VBZ	B-VP	O
3.4	3.4	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
shows	show	VBZ	B-VP	O
overall	overall	JJ	B-NP	O
unchanged	unchanged	JJ	I-NP	O
ill-defined	ill-defined	JJ	I-NP	O
right	right	JJ	I-NP	O
hilar	hilar	JJ	I-NP	O
mass	mass	NN	I-NP	O
and	and	CC	O	O
prior	prior	JJ	B-NP	O
new	new	JJ	I-NP	O
faint	faint	JJ	I-NP	O
parenchymal	parenchymal	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
concerning	concern	VBG	B-PP	O
to	to	TO	B-PP	O
early	early	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
postobstructive	postobstructive	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
tachy	tachy	JJ	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Head	Head	NNP	B-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
right	right	JJ	I-NP	O
MCA	MCA	NNP	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
MR	MR	NNP	I-NP	I-protein
,	,	,	O	O
EF	EF	NNP	B-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
right-handed	right-handed	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
non-small-cell	non-small-cell	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
ICA	ICA	NN	I-NP	O
stroke	stroke	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
3/1/06	3/1/06	CD	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
for	for	IN	B-PP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
UTI	UTI	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
nursing	nurse	VBG	B-VP	O
home	home	NN	B-ADVP	O
for	for	IN	B-PP	O
altered	altered	JJ	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

Found	Found	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
pyuria	pyuria	NN	B-NP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
oxalate	oxalate	NN	I-NP	O
crystal	crystal	NN	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
postobstructive	postobstructive	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
bandemia	bandemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
postobstructive	postobstructive	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
pyuria	pyuria	NN	B-NP	O
with	with	IN	B-PP	O
yeast	yeast	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
briefly	briefly	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	O	O
added	add	VBN	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
also	also	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
Ceptaz	Ceptaz	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
for	for	IN	B-PP	O
pseudomonas	pseudomona	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
yeast	yeast	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
on	on	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
improving	improve	VBG	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
brief	brief	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
that	that	WDT	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
required	require	VBN	I-VP	O
no	no	DT	B-NP	O
escalation	escalation	NN	I-NP	O
in	in	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
and	and	CC	O	O
tolerated	tolerate	VBD	B-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP$	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
14	14	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
got	get	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
that	that	WDT	B-NP	O
shows	show	VBZ	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
lung	lung	NN	I-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
emphysema	emphysema	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
consolidation	consolidation	NN	I-NP	O
is	be	VBZ	B-VP	O
contiguous	contiguous	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hilum	hilum	NN	I-NP	O
and	and	CC	O	O
underlying	underlie	VBG	B-VP	O
hilar	hilar	JJ	B-NP	O
adenopathy	adenopathy	JJ	I-NP	O
or	or	CC	I-NP	O
hilar	hilar	JJ	I-NP	O
mass	mass	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
excluded	exclude	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
small	small	JJ	B-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Szufat	Szufat	NNP	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	I-VP	O
having	have	VBG	I-VP	O
post	post	IN	B-PP	O
XRT	XRT	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
finish	finish	VB	I-VP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
shows	show	VBZ	B-VP	O
yeast	yeast	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
UTI	UTI	NN	I-NP	O
currently	currently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
fluconazole	fluconazole	NN	B-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
has	have	VBZ	B-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
waxing	waxing	NN	I-NP	O
and	and	CC	I-NP	O
waning	waning	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
has	have	VBZ	B-VP	O
greatly	greatly	RB	I-VP	O
improved	improve	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
although	although	IN	B-SBAR	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hallucinations	hallucination	NNS	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
example	example	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
thinking	think	VBG	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
resident	resident	NN	I-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
niece	niece	NN	I-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
,	,	,	O	O
onch	onch	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
geriatrics	geriatric	NNS	B-NP	O
was	be	VBD	B-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
son	son	NN	I-NP	O
's	's	POS	B-NP	O
request	request	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
psy	psy	NN	B-NP	O
onc	onc	NN	I-NP	O
and	and	CC	O	O
geriatrics	geriatric	NNS	B-NP	O
believed	believe	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
is	be	VBZ	B-VP	O
multifactorial	multifactorial	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
delirium	delirium	NN	B-NP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
dementia	dementia	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
avoiding	avoid	VBG	I-VP	O
pain	pain	NN	B-NP	O
meds	med	NNS	I-NP	O
and	and	CC	O	O
oversedating	oversedate	VBG	B-NP	O
meds	med	NNS	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
zyprexa	zyprexa	NN	B-NP	O
5mg	5mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
prn	prn	VBP	B-VP	O
agitation	agitation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
can	can	MD	B-VP	O
increase	increase	VB	I-VP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
po	po	NN	I-NP	O
qhs	qh	NNS	I-NP	O
if	if	IN	B-SBAR	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Lamictal	Lamictal	JJ	I-NP	O
and	and	CC	I-NP	O
Cymbalta	Cymbalta	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
further	further	RB	I-NP	O
neurological	neurological	JJ	I-NP	O
decompensation	decompensation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Seroquel	Seroquel	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
and	and	CC	O	O
Zydis	Zydis	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
receiving	receive	VBG	I-VP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
agitated	agitate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
seroquel	seroquel	NN	B-NP	O
on	on	IN	B-PP	O
3/11	3/11	CD	B-NP	O
early	early	JJ	I-NP	O
am	am	NN	I-NP	O
and	and	CC	O	O
got	get	VBD	B-VP	O
really	really	RB	B-ADVP	O
over	over	IN	B-PP	O
sedated	sedate	VBN	B-VP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
receiving	receive	VBG	I-VP	O
seroquel	seroquel	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
for	for	IN	B-PP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
oversedation	oversedation	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
controlled	control	VBN	B-NP	O
prolonged	prolong	VBN	I-NP	O
QTC	QTC	NN	I-NP	O
on	on	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Haldol	Haldol	NN	I-NP	O
was	be	VBD	B-VP	O
DC	DC	NN	B-NP	B-cell_type
'd	'd	MD	B-VP	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
Zyprexa	Zyprexa	NNP	B-NP	O
and	and	CC	I-NP	O
Seroquel	Seroquel	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKGs	EKG	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stays	stay	NNS	I-NP	O
.	.	.	O	O

Heme/Onch	Heme/Onch	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
stage	stage	NN	B-NP	O
III	III	CD	I-NP	O
non-small-cell	non-small-cell	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
oncologist	oncologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Miquel	Miquel	NNP	I-NP	O
Grothe	Grothe	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Nawin	Nawin	NNP	I-NP	O
Tayjeune	Tayjeune	NNP	I-NP	O
Antri	Antri	NNP	I-NP	O
-	-	HYPH	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
psycho/onch	psycho/onch	NN	I-NP	O
social	social	JJ	I-NP	O
worker	worker	NN	I-NP	O
whose	whose	WP$	B-NP	O
name	name	NN	I-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Hugh	Hugh	NNP	I-NP	O
Dress	Dress	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
psych/onch	psych/onch	NN	B-NP	O
and	and	CC	I-NP	O
geriatric	geriatric	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Kiel	Kiel	NNP	I-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
treatment	treatment	NN	I-NP	O
planned	plan	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
sees	see	VBZ	B-VP	O
her	her	PRP	B-NP	O
again	again	RB	B-ADVP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
currently	currently	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
medical	medical	JJ	I-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-VP	O
receive	receive	VB	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
levothyroxine	levothyroxine	NN	I-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
Graves	Graves	NN	B-NP	O
'	'	POS	B-NP	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
radioiodine	radioiodine	NN	B-NP	O
ablation	ablation	NN	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
speech	speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
for	for	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
dysphagia	dysphagia	NN	B-NP	O
and	and	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
with	with	IN	B-PP	O
swallowing	swallow	VBG	B-VP	O
and	and	CC	I-VP	O
eating	eat	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
video	video	NN	I-NP	O
flow	flow	NN	I-NP	O
examination	examination	NN	I-NP	O
shows	show	VBZ	B-VP	O
prolonged	prolonged	JJ	B-NP	O
oral	oral	JJ	I-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
video	video	NN	I-NP	O
swallow	swallow	VB	B-VP	O
examination	examination	NN	B-NP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
mince	mince	NN	I-NP	O
ground	ground	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
thin	thin	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
.	.	.	O	O

Alternate	Alternate	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
and	and	CC	I-NP	O
solids	solid	NNS	I-NP	O
with	with	IN	B-PP	O
tongue	tongue	NN	B-NP	O
sweep	sweep	NN	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
residue	residue	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
to	to	TO	I-VP	O
sit	sit	VB	I-VP	O
upright	upright	RB	B-ADVP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
small	small	JJ	B-NP	O
bites	bite	NNS	I-NP	O
and	and	CC	I-NP	O
sips	sip	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
speech	speech	NN	B-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
for	for	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
swallow	swallow	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
nutrition	nutrition	NN	B-NP	O
consult	consult	NN	I-NP	O
who	who	WP	B-NP	O
started	start	VBD	B-VP	O
the	the	DT	B-NP	O
calorie	calorie	NN	I-NP	O
counts	count	NNS	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
need	need	VBN	I-VP	O
long-term	long-term	JJ	B-NP	O
nutritional	nutritional	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
meet	meet	VB	I-VP	O
her	her	PRP$	B-NP	O
nutritional	nutritional	JJ	I-NP	O
goal	goal	NN	I-NP	O
.	.	.	O	O

That	That	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
deferred	defer	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
doctors	doctor	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
assists	assist	NNS	B-NP	O
and	and	CC	O	O
encouragement	encouragement	NN	B-NP	O
with	with	IN	B-PP	O
feeding	feeding	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
and	and	CC	O	O
replete	replete	VB	B-VP	O
her	her	PRP$	B-NP	O
lytes	lyte	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
American	American	JJ	I-NP	O
Diabetic	Diabetic	JJ	I-NP	O
Diet	Diet	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lovenox	Lovenox	NN	B-NP	O
and	and	CC	I-NP	O
PPI	PPI	NN	I-NP	B-protein
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
headache	headache	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dulcolax	Dulcolax	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Dilaudid	Dilaudid	VBD	B-VP	O
1-2	1-2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Ibuprofen	Ibuprofen	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
temperature	temperature	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
125	125	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Ritalin	Ritalin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
x14	x14	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
two	two	CD	I-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	VBP	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
b.i.d.	b.i.d.	FW	I-NP	I-protein
18	18	CD	I-NP	I-protein
.	.	.	O	O

Compazine	Compazine	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
subq	subq	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Lamictal	Lamictal	JJ	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x14	x14	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

23	23	CD	B-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

Combivent	Combivent	NNP	B-NP	O
neb	neb	NN	I-NP	O
q.	q.	NNP	B-NP	O
6h	6h	CD	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

25	25	CD	B-NP	O
.	.	.	O	O

Zydis	Zydis	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

26	26	CD	B-NP	O
.	.	.	O	O

Lidoderm	Lidoderm	NN	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
patch	patch	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

27	27	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	O	O
q.h.s.	q.h.s.	NN	B-NP	O
28	28	CD	I-NP	O
.	.	.	O	O

Cymbalta	Cymbalta	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Ratley	Ratley	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-8697387	1-8697387	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Lesley	Lesley	NNP	B-NP	O
Scoh	Scoh	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LICALZI	LICALZI	NNP	B-NP	O
,	,	,	O	O
ELTON	ELTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ESTIS	ESTIS	NNP	B-NP	O
,	,	,	O	O
FAUSTINO	FAUSTINO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5243210	5243210	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/24/06	9/24/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/24/06	9/24/06	CD	B-NP	O

